Biology subjects

Holmqvist, E.

Publications and source records attributed to Holmqvist, E..

4 recordsLinked to original sources

bioRxiv2026

Distinct plasmid- and host-encoded mechanisms drive small plasmid copy number-mediated heteroresistance in Escherichia coli

Antibiotic heteroresistance, the presence of a rare resistant subpopulation within an otherwise susceptible bacterial population, poses a significant clinical challenge. Understanding its genetic mechanisms is critical for early detection and treatment efficacy. Here, we investigate the contribution of small plasmids to heteroresistance using a clinical bloodstream Escherichia coli isolate carrying a 12 kb ColE1-type plasmid (p12). We show that this plasmid drives transient {beta}-lactam heteroresistance through massive increases in plasmid copy number. Two distinct genetic mechanisms drive this amplification: mutations in the plasmid RNAI/RNAII that deregulate replication control, and a chromosomal recD mutation that induces multimerization and a shift toward rolling-circle replication. Notably, this recD-mediated amplification is restricted to small ColE1 and F- plasmids. This study highlights the crucial role of small plasmids in resistance evolution, demonstrating that they can cause this phenotype via alternative genetic pathways, without the involvement of traditional large resistance plasmids.

microbiology↗

bioRxiv2026

OmrA sRNA Inhibits Translation of Phosphoenolpyruvate Carboxylase to Impair TCA-Cycle Flux

Small RNAs (sRNAs) rarely cause strong growth phenotypes upon overexpression, complicating efforts to link regulatory interactions to physiological outcomes. Here, we report that high levels of the Escherichia coli sRNA OmrA, but not its sibling OmrB, severely inhibit growth in glucose minimal medium. Genetic, biochemical, and physiological analyses indicate that OmrA-dependent toxicity results from reduced flux through the tricarboxylic acid (TCA) cycle. A UV-based suppressor screen identified mutations in the gene encoding Hfq, the RNA-chaperone that aids sRNA-mRNA interactions. Secondly, three independent mutations clustered in the ribosome-binding site of ppc, encoding phosphoenolpyruvate carboxylase, a key anaplerotic enzyme. OmrA directly inhibits Ppc translation via Hfq-dependent base-pairing in the ppc 5' UTR, including the mutated nucleotides obtained in the genetic screen. OmrA is significantly more effective than OmrB in ppc repression in vivo and in vitro, consistent with sequence divergence in their central regions. Supplementation with glutamate, glutamine, or downstream TCA cycle metabolites fully restores growth, linking reduced Ppc levels to metabolic limitation. These results identify ppc as a physiologically relevant OmrA target and suggest how RNA toxicity can uncover central metabolic nodes used by sRNAs to modulate bacterial physiology.

microbiology↗

bioRxiv2025

The pcnB gene sustains Shigella flexneri virulence

The enteropathogen Shigella flexneri employs a Type Three Secretion System (T3SS) to colonize intestinal epithelial cells. Genes encoding the T3SS are located on a large IncFII virulence plasmid, pINV. T3SS expression comes at the expense of slowed Shigella growth and is therefore strictly controlled by both transcriptional and post-transcriptional mechanisms. Following up on a recent genome-wide screen, we here show that the chromosomal gene pcnB, encoding the poly-A polymerase I (PAP-I), slows Shigella growth at 37{degrees}C, while at the same time promotes early colonization of a human epithelial enteroid model. Proteomic profiling revealed that pcnB drives global increase of the Shigella T3SS virulence program. Accordingly, pcnB sustains pINV replication to a level optimal for Shigella virulence. This is achieved through increased degradation of the antisense RNA CopA, involved in plasmid replication control. The pcnB effect on pINV replication was found to also ensure longer-term intraepithelial expansion of Shigella following human intestinal epithelium invasion. Our findings exemplify how an optimal pINV level is necessary for the execution of Shigellas infection cycle. AUTHOR SUMMARYBacterial infections represent a major global threat. Understanding the genetic determinants promoting infections is crucial to overcome this threat. Shigella is an intracellular bacterial pathogen that invades and disseminates in the intestinal epithelium, causing bacillary dysentery in humans. Shigellas ability to cause disease relies on the delivery of effector proteins into the host cells through an injection machinery, with most of the genes involved in this process located on a large virulence plasmid. Here we show that the chromosomal gene pcnB sustains an optimal virulence plasmid level. This is crucial for Shigella to maximize virulence protein expression and thereby efficiently invade, replicate and spread within the intestinal epithelium.

microbiology↗

bioRxiv2022

Rescue of Escherichia coli auxotrophy by de novo small proteins

Increasing numbers of small proteins with diverse physiological roles are being identified and characterized in both prokaryotic and eukaryotic systems, but the origins and evolution of these proteins remain unclear. Recent genomic sequence analyses in several organisms suggest that new functions encoded by small open reading frames (sORFs) may emerge de novo from noncoding sequences. However, experimental data demonstrating if and how randomly generated sORFs can confer beneficial effects to cells are limited. Here we show that by up-regulating hisB expression, de novo small proteins ([≤] 50 amino acids in length) selected from random sequence libraries can rescue Escherichia coli cells that lack the conditionally essential SerB enzyme. The recovered small proteins are hydrophobic and confer their rescue effect by binding to the 5 end regulatory region of the his operon mRNA, suggesting that protein binding promotes structural rearrangements of the RNA that allow increased hisB expression. This study adds RNA regulatory elements as another interacting partner for de novo proteins isolated from random sequence libraries, and provides further experimental evidence that small proteins with selective benefits can originate from the expression of nonfunctional sequences.

evolutionary biology↗